Weekly Dose #54 - Vaccine trial halted; Hyperimmune trial begins; IV tramadol rejected; FDA votes on schizophrenia, bipolar Tx; And a first in Ebola treatment

<p><span style="font-weight: 400;">This week: News of another vaccine trial being put on hold; A trial assessing hyperimmue globulin beings; An NDA for IV tramadol is rejected; FDA Committees vote on novel schizophrenia and bipolar I disorder therapy; And a first approval for Ebola. </span></p>